Global Outlook for the Cryosurgery Devices Market to 2025 - Rising Preference for Minimally Invasive Surgeries Driving Market Growth -

DUBLIN--()--The "Cryosurgery Devices Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to's offering.

The cryosurgery devices market is expected to grow due to increasing disorders such as cardiovascular diseases and skin disorders. The oncology segment is expected to hold a major share in the cryosurgery devices market owing to the higher prevalence of cancer and rising preference towards minimally invasive surgery. According to the World Health Organization, the burden of cancer in 2018 was around 18.1 million cases globally. It is the second leading cause of death worldwide, causing around 9.6 million deaths according to the above-mentioned source.

Furthermore, cryoablation has been observed to be very effective in the treatment of breast carcinomas over the percutaneous ablation method. According to the World Health Organization, in 2018, lung and breast cancer are the most prevalent and approximately 2.1 million were diagnosed with it. Therefore, the aforementioned factors are expected to impact positively on the cryosurgery devices market.

North America is expected to be a dominant region for the studied market owing to the increasing burden of chronic disorders and the presence of product approvals. According to the National Cancer Institute, in 2018, approximately 1.74 million were diagnosed with cancer in the United States. Furthermore, in 2019, the US FDA approved two cryosurgical devices CryoTouch' and CryoLab' developed by Cryoconcepts. Cryotouch is a portable device that delivers cryogen to the targeted lesions while the cryolab is involved in high volume surgeries. These have been approved for 23 indications. Hence, such factors are expected to drive the cryosurgery market in North America.

Some of the companies which are currently dominating the market are Harvard Bioscience Inc., AtriCure Inc., Brymill Cryogenic Systems, Cardinal Health, CryoConcepts, Cortex Technology, Bovie, and Cooper Surgical

Key Topics Covered:


1.1 Study Assumptions

1.2 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.2.1 Growing Burden of Chronic Diseases

4.2.2 Rising Preference for Minimally Invasive Surgeries

4.3 Market Restraints

4.3.1 Stringent Regulatory Guidelines and Reimbursement Issues

4.4 Porter's Five Force Analysis

4.4.1 Threat of New Entrants

4.4.2 Bargaining Power of Buyers/Consumers

4.4.3 Bargaining Power of Suppliers

4.4.4 Threat of Substitute Products

4.4.5 Intensity of Competitive Rivalry


5.1 By Product Type

5.1.1 Tissue Contact Probes

5.1.2 Tissue Spray Probes

5.1.3 Epidermal & Subcutaneous Cryoablation Devices

5.2 By Application

5.2.1 Surgeries Oncology Cardiology Dermatology Other

5.2.2 Pain Management

5.2.3 Recovery, Health and Beauty

5.3 By End User

5.3.1 Hospital

5.3.2 Cryotherapy Centre

5.4 Geography


6.1 Company Profiles

6.1.1 ArtiCure Inc.

6.1.2 Bovie

6.1.3 Brymill Cryogenic Systems

6.1.4 BVM Medical

6.1.5 Cardinal Health

6.1.6 CryoConcepts

6.1.7 Cortex Technology

6.1.8 Cooper Surgical

6.1.9 Harvard Bioscience Inc.

6.1.10 Premier Medical Co.


For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900